A recent study published in PubMed highlights the clinicopathological features and outcomes of immature PIT-1 lineage tumors, identified as a high-risk subtype of pituitary neuroendocrine tumors according to WHO 2022. This research provides valuable insights into the characteristics and prognosis of this rare tumor type.
clinicopathological features and outcomes of immature pit 1 lineage tumors a high risk pituitary neuroendocrine tumor pituitary adenoma subtype per who 2022
Original title: “Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022.”